Palvella Therapeutics (PVLA) Misses Q1 EPS by 120c
Tweet
Share
E-mailGet Alerts PVLA Hot Sheet
Join SI Premium – FREE
Palvella Therapeutics (NASDAQ: PVLA) reported Q1 EPS of ($1.20).
For earnings history and earnings-related data on Palvella Therapeutics (PVLA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FDA grants rolling review for Palvella's rapamycin NDA for rare condition
- H.C. Wainwright Reiterates Buy Rating on MapLight Therapeutics (MPLT)
- Micron Technology (MU) PT Raised to $1,550 at Needham
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
